- Generic name
- Piperacillin + Tazobactam
- Strength
- 4 gm + .5 gm/vial
- Dosage form
- Injection
- Manufactured by
- Advanced Chemical Industries PLC
Tazosyn Injection
About Tazosyn 4 gm + .5 gm/vial Injection
Tazosyn is an injection that combines a penicillin antibiotic with a beta-lactamase inhibitor. It is given by a healthcare professional to treat certain moderate to severe bacterial infections.
There are 8 brands of Piperacillin + Tazobactam listed in Bangladesh. The lowest listed price is Brodactam (2 gm+0.25 gm)/vial IV Infusion at ৳ 602.00 per unit.
What is Tazosyn 4 gm + .5 gm/vial Injection?
Tazosyn is a combination antibiotic injection. It contains piperacillin, a penicillin-type drug that kills many bacteria by interfering with their cell walls, and tazobactam, which blocks enzymes that some bacteria use to resist penicillins. Together they are intended to cover a wider range of bacteria, including some that would otherwise be resistant. It is given intravenously in a hospital or clinic setting for moderate to severe infections caused by bacteria that are expected to respond. The doctor chooses the dose and course based on the infection and the patient's condition.
Uses of Tazosyn
Tazosyn is used for moderate to severe infections caused by bacteria that are expected to be susceptible to the combination. The available information lists intra-abdominal infections among the conditions treated. It is not for viral infections or for mild infections that can be treated with other medicines. Only a doctor can decide whether this antibiotic is appropriate for a particular infection.
How to use Tazosyn
Tazosyn is given by intravenous infusion by a doctor or nurse, usually over about half an hour. It is not for self-administration at home. The doctor sets the dose, the interval between doses, and how many days the course should last, taking into account the type and severity of the infection. Do not change or stop the course on your own; ask the treating team if you have questions about the schedule.
Side effects of Tazosyn
Common side effects involve the skin, such as rash and itching, and the stomach and bowel, such as diarrhoea, constipation, nausea, vomiting, indigestion and abdominal pain. Some people have fever, chills, or a reaction at the injection site. Less common effects include allergic reactions, low blood sugar, muscle or joint pain, and sleep problems. Serious allergic reactions and severe skin reactions can occur. Tell the doctor or nurse promptly if you notice a rash or feel unwell during or after treatment.
Safety and precautions
Do not receive Tazosyn if you have had an allergic reaction to penicillins, cephalosporins or beta-lactamase inhibitors. Tell the doctor about any allergy or previous reaction to antibiotics. Serious allergic reactions, including anaphylaxis, have been reported, and treatment should be stopped if one occurs. Severe skin reactions have also been reported. Blood counts may need checking during long courses. The medicine crosses the placenta, and piperacillin passes into breast milk; information on use in pregnancy and breastfeeding is limited, so ask the doctor if you are pregnant, planning pregnancy or breastfeeding.
Frequently asked questions
What does the dosage form and strength of Tazosyn mean?
Tazosyn is supplied as an injection in a vial containing 4 gm of piperacillin plus .5 gm of tazobactam. The strength shows the amount of each ingredient in the vial. The doctor decides how much to give and how often.
What is Tazosyn used for and what kind of medicine is it?
Tazosyn is a combination antibiotic injection used for moderate to severe bacterial infections, including intra-abdominal infections, when the bacteria are expected to be susceptible. It contains a penicillin-type antibiotic and a beta-lactamase inhibitor. It does not treat viral infections.
Who should avoid Tazosyn or ask the doctor first?
People with a history of allergic reactions to penicillins, cephalosporins or beta-lactamase inhibitors should not receive it. Tell the doctor if you are pregnant, breastfeeding, have kidney problems, or have had a rash or reaction to antibiotics, so the risks can be weighed.
Can Tazosyn be given at home or by the patient?
No. Tazosyn is given by intravenous infusion by a doctor or nurse, usually in a hospital or clinic. It is not for self-administration. Ask the treating team about the schedule and what to do if you notice any reaction.
Indications
Intra-abdominal Infections: Appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of Escherichia coli or the following members of the Bacteroides fragilis group: B. fragilis, B. ovatus, B. thetaiotaomicron, or B. vulgatus.
Skin and Skin Structure Infections: Uncomplicated and complicated skin and skin structure infections, including Cellulites, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of Staphylococcus aureus.
Female Pelvic Infections: Postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of Escherichia coli.
Community-acquired pneumonia: Community-acquired pneumonia (moderate severity only) caused by β lactamase producing isolates of Haemophilus influenzae.
Nosocomial pneumonia: Nosocomial pneumonia (moderate to severe) caused by β-lactamase producing isolates of Staphylococcus aureus and by piperacillin/tazobactam-susceptible Acinetobacter baumanii, Haemophilus influenzae, Klebsiella pneumoniae, and Pseudomonas aeruginosa (Nosocomial pneumonia caused by P. aeruginosa should be treated in combination with an aminoglycoside).
Pharmacology
Dosage & Administration
Adult Patients: The usual total daily dose of Piperacillin and tazobactam for adults is 3.375 g every six hours totaling 13.5 g (12.0 g piperacillin/1.5 g tazobactam). The usual duration of treatment is from 7 to 10 days.
Nosocomial Pneumonia: Initial presumptive treatment of patients with nosocomial pneumonia should start with piperacillin and tazobactam at a dosage of 4.5 g every six hours plus an aminoglycoside, totaling 18.0 g (16.0 g piperacillin/2.0 g tazobactam). The recommended duration of the treatment for nosocomial pneumonia is 7 to 14 days. Treatment with the aminoglycoside should be continued in patients from whom Pseudomonas aeroginosa is isolated.
Pediatric Patients: For children with appendicitis and/or peritonitis 9 months of age or older, weighing up to 40 kg, and with normal renal function, the recommended piperacillin and tazobactam dosage is 100 mg piperacillin/12.5 mg tazobactam per kilogram of body weight, every 8 hours. For pediatric patients between 2 months and 9 months of age, the recommended dosage based on Pharmacokinetic modeling, is 80 mg piperacillin/10 mg tazobactam per kilogram of body weight, every 8 hours. Pediatric patients weighing over 40 kg and with normal renal function should receive the adult dose. It has not been determined how to adjust piperacillin and tazobactam dosage in pediatric patients with renal impairment.
Interaction
Sequential administration of pipercillin and tazobactam and tobramycin to patients with either normal renal function or mild to moderate renal impairment has been shown to modestly decrease serum concentrations of tobramycin but no dosage adjustment is considered necessary.
Probenecid: Probenecid administered concomitantly with piperacillin and tazobactam prolongs the half-life of piperacillin by 21% and that of tazobactam by 71% because probenecid inhibits tubular renal secretion of both piperacillin and tazobactam. Probenecid should not be co-administered with Pipercillin and tazobactam unless the benefit outweighs the risk.
Anticoagulants: Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin, oral anticoagulants, or other drugs that may affect the blood coagulation system or the thrombocyte function.
Vecuronium: Piperacillin when used concomitantly with vecuronium has been implicated in the prolongation of the neuromuscular blockade of vacuronium, piperacillin and tazobactam could produce the same phenomenon if given along with vecuronium. Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.
Methotrexate: Limited data suggests that co-administration of methotrexate and piperacillin may reduce the clearance of methotrexate due to competition for renal secretion. The impact of tazobactam on the elimination of methotrexate has not been evaluated. If concurrent therapy is necessary, serum concentrations of methotrexate as well as the signs and symptoms of methotrexate toxicity should be frequently monitored.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Piperacillin and tazobactam may cause severe cutaneous adverse reactions, such as Stevens- Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, and acute generalized exanthematous pustulosis. Discontinue Piperacillin and tazobactam for progressive rashes.
Hematological effects (including bleeding, leukopenia and neutropenia) have occurred. Monitor hematologic tests during prolonged therapy.
Nephrotoxicity in critically ill patients has been observed; the use of Piperacillin and tazobactam was found to be an independent risk factor for renal failure and was associated with delayed recovery of renal function as compared to other beta-lactam antibacterial drugs in a randomized, multicenter, controlled trial in critically ill patients. Based on this study, alternative treatment options should be considered in the critically ill population. If alternative treatment options are inadequate or unavailable, monitor renal function during treatment with Piperacillin and tazobactam.
Clostridium difficile associated diarrhea: Evaluate patients if diarrhea occurs.
Overdose Effects
Storage Conditions
Alternative brands of Piperacillin + Tazobactam
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.